- Home
- CRVS vs CAN Comparison
CRVS vs CAN Comparison
Compare CRVS & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVS | CAN |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.0M | 511.2M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CRVS | CAN |
|---|---|---|
| Price | $7.43 | $0.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $13.75 | $3.56 |
| AVG Volume (30 Days) | 1.6M | ★ 22.0M |
| Earning Date | 11-04-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $422,228,000.00 |
| Revenue This Year | N/A | $91.42 |
| Revenue Next Year | N/A | $47.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 83.87 |
| 52 Week Low | $2.54 | $0.53 |
| 52 Week High | $9.60 | $2.47 |
Technical Indicators
Market Signals| Indicator | CRVS | CAN |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 39.62 |
| Support Level | $7.47 | $0.77 |
| Resistance Level | $8.00 | $0.89 |
| Average True Range (ATR) | 0.54 | 0.06 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 0.00 | 14.85 |
Price Performance
Historical ComparisonAbout CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.